88
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Validation of the Spanish Version of the VERITAS-PRN Scale to Assess Adherence to on Demand Regimens in Patients with Hemophilia

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 967-974 | Published online: 11 May 2021

References

  • Molho P, Rolland N, Lebrun T, et al. Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. Haemophilia. 2000;6(1):23–32. doi:10.1046/j.1365-2516.2000.00358.x
  • White GC, Rosendaal F, Aledort LM, et al. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001;85(3):560. doi:10.1055/s-0037-1615621
  • Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al.; Treatment Guidelines Working Group on Behalf of The World Federation of Hemophilia. Guidelines for the management of hemophilia. Haemophilia. 2013;19:e1–e47.
  • Soucie JM, Cianfrini C, Janco RL, et al. Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors. Blood. 2004;103(7):2467–2473. doi:10.1182/blood-2003-05-1457
  • Berntorp E, Shapiro AD. Modern haemophilia care. Lancet. 2012;379(9824):1447–1456. doi:10.1016/S0140-6736(11)61139-2
  • Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535–544. doi:10.1056/NEJMoa067659
  • Windyga J. Is continuous low-dose prophylaxis superior to on-demand treatment for patients with hemophilia? Semin Thromb Hemost. 2016;42(5):533–540. doi:10.1055/s-0036-1579639
  • Zappa S, McDaniel M, Marandola J, Allen G. Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey. Haemophilia. 2012;18(3):e140–e153. doi:10.1111/j.1365-2516.2012.02770.x
  • Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. doi:10.1056/NEJMra050100
  • Tran DQ, Barry V, Antun A, Ribeiro M, Stein S, Kempton CL. Physician trust and depression influence adherence to factor replacement: a Single-Centre Cross-Sectional Study. Haemophilia. 2017;23(1):98–104. doi:10.1111/hae.13078
  • Duncan NA, Kronenberger WG, Roberson CP, Shapiro AD. VERITAS-PRN: a new measure of adherence to episodic treatment regimens in haemophilia. Haemophilia. 2010;16(1):47–53. doi:10.1111/j.1365-2516.2009.02094.x
  • Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use. 4rd ed. Oxford: Oxford University Press; 2008.
  • McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4(4):293–307. doi:10.1007/BF01593882
  • Nazzaro AM. Where are we: preliminary results of the national hemophilia foundation’s prevention program baseline survey of health knowledge, attitudes, and behaviors in the hemophilia population. HemAware. 2000;20–5:24–25.
  • Lindvall K, Colstrup L, Wollter IM, et al. Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia. Haemophilia. 2006;12(1):47–51. doi:10.1111/j.1365-2516.2006.01192.x
  • Hacker MR, Geraghty S, Manco-Johnson M. Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia. 2001;7(4):392–396. doi:10.1046/j.1365-2516.2001.00534.x
  • Saxena K. Barriers and perceived limitations to early treatment of hemophilia. J Blood Med. 2013;4:49–56. doi:10.2147/JBM.S43734
  • McLaughlin JM, Witkop ML, Lambing A, Anderson TL, Munn J, Tortella B. Better adherence to prescribed treatment regimen is related to less chronic pain among adolescents and young adults with moderate or severe haemophilia. Haemophilia. 2014;20(4):506–512. doi:10.1111/hae.12360
  • Pasta G, Mancuso ME, Perfetto OS, Solimero LP. Radiosynoviorthesis in children with haemophilia. Hämostaseologie. 2009;29(1):S62–64. doi:10.1055/s-0037-1621502